Top Markets
#1 Cryptopia Cryptopia +48.58%
#2 Merlin's Seal BTC Merlin's Seal BTC +42.76%
#3 SAFEcoin SAFEcoin +29.19%
#4 0G 0G +27.35%
#5 Pons Pons +25.75%
#6 AI XOVIA AI XOVIA +25.33%
#7 Zora Zora +24.85%
#8 QuantixAI QuantixAI +24.35%
#9 Verus Coin Verus Coin +17.85%
#10 ADO Protocol ADO Protocol +17.27%
Coin of the day
Cryptopia Cryptopia
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Hansa Biopharma AB (publ) Hansa Biopharma AB (publ)

Hansa Biopharma AB (publ)

HNSA
Classement en actions #13465
Hansa Biopharma AB (publ) is a biopharmaceutical firm dedicated to developing... Hansa Biopharma AB (publ) is a biopharmaceutical firm dedicated to developing immunomodulatory therapies. Leveraging its unique enzyme technology platform, the company targets treatments that facilitate organ transplants and address rare autoimmune conditions driven by immunoglobulin G (IgG), alongside applications in gene therapy and cancer. Its primary drug candidate, Imlifidase, an enzyme therapy designed to cleave antibodies, is currently undergoing Phase 3 clinical trials for use in patients awaiting sensitized kidney transplants and those with anti-GBM antibody disease. Imlifidase is also in Phase 2 trials for treating antibody-mediated kidney transplant rejection and Guillain Barré syndrome. Further pipeline developments include NiceR (Novel immunoglobulin cleaving enzymes for Repeat dosing) for autoimmune diseases, transplantation, and oncology, as well as EnzE (Enzyme based antibody Enhancement) for cancer immunotherapy. Hansa Biopharma also has a preclinical research partnership with argenx BV, exploring the synergistic potential of their respective IgG-modulating technologies. Established in 2007, the company's headquarters are located in Lund, Sweden.
Prix de l'action
$4.88
Capitalisation boursière
$487.02M
Changement (1 jour)
-1.84%
Changement (1 an)
42.78%
Pays
SE
Échange Hansa Biopharma AB (publ) (HNSA)

Catégorie

Healthcare
Historique du prix de l'action pour Hansa Biopharma AB (publ) (HNSA)
Prix de clôture le plus élevé : $4.66 le 2026-08-01

Prix de clôture le plus bas : $1.23 le 2007-10-01
Historique du prix de l'action de Hansa Biopharma AB (publ) de 2007 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 3.22%
2025 18.06%
2024 24.12%
2023 -52.92%
2022 -47.02%
2021 -65.69%
2020 170.40%
2019 -67.23%
2018 9.70%
2017 122.57%
2016 324.99%
2015 -11.09%
2014 181.45%
2013 131.04%
2012 -16.18%
2011 22.26%
2010 -23.87%
2009 62.04%
2008 -57.53%
2007 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $538.60 37.74%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 43.09%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $141.48 487.28%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $751.98 6.17%
CH